SEC Filing

Investor Contacts

Katherine A. Littrell, PhD, RN
Vice President, Investor Relations

Diane H. Schrick
Senior Director, Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Jul 5, 2019
Document Date
Jul 5, 2019
Form Description
CT ORDER
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
Jazz Pharmaceuticals plc